Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Imbach

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Global Biogeochemical Cycles|December 29, 2015
Spatial and temporal contrasts in the distribution of crops and pastures across Amazonia: A new agricultural land use data set from census data since 1950P Imbach, M Manrow, E Barona, et al.
Blut|June 1, 1984
Intravenous immunoglobulin therapy: new aspects and outlookP Imbach, S Barandun, C Baumgartner, et al.
Medical and Pediatric Oncology|December 24, 1997
"Pancreatoblastoma in childhood: the role of alpha-fetoprotein"E Bergstraesser, H Ohnacker, B Stamm, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitorsP Imbach, H G Capraro, P Furet, et al.
Lancet (London, England)|January 19, 1980
Severe bleeding associated with defective thromboxane synthetaseF Mestel, O Oetliker, E Beck, et al.
Helvetica Paediatrica Acta|February 1, 1981
High-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhoodP Imbach, S Barandun, C Baumgartner, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1995
Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology GroupP Imbach, A Fuchs, W Berchtold, et al.
Vox Sanguinis|January 1, 1991
Safety of intravenous immunoglobulin preparations: a prospective multicenter study to exclude the risk of non-A, non-B hepatitisP Imbach, B A Perret, R Babington, et al.
Blut|July 1, 1989
Commentary on the management of autoimmune thrombocytopenia during pregnancy and in the neonatal periodV S Blanchette, R A Sacher, P J Ballem, et al.
Schweizerische Medizinische Wochenschrift|August 5, 1978
[Drug induced agranulocytosis. Improved prognosis due to better supportive care]H P Honegger, M Graf, A von Felten, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Global Biogeochemical Cycles|December 29, 2015
Spatial and temporal contrasts in the distribution of crops and pastures across Amazonia: A new agricultural land use data set from census data since 1950P Imbach, M Manrow, E Barona, et al.
Blut|June 1, 1984
Intravenous immunoglobulin therapy: new aspects and outlookP Imbach, S Barandun, C Baumgartner, et al.
Medical and Pediatric Oncology|December 24, 1997
"Pancreatoblastoma in childhood: the role of alpha-fetoprotein"E Bergstraesser, H Ohnacker, B Stamm, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitorsP Imbach, H G Capraro, P Furet, et al.
Lancet (London, England)|January 19, 1980
Severe bleeding associated with defective thromboxane synthetaseF Mestel, O Oetliker, E Beck, et al.
Helvetica Paediatrica Acta|February 1, 1981
High-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhoodP Imbach, S Barandun, C Baumgartner, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1995
Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology GroupP Imbach, A Fuchs, W Berchtold, et al.
Vox Sanguinis|January 1, 1991
Safety of intravenous immunoglobulin preparations: a prospective multicenter study to exclude the risk of non-A, non-B hepatitisP Imbach, B A Perret, R Babington, et al.
Blut|July 1, 1989
Commentary on the management of autoimmune thrombocytopenia during pregnancy and in the neonatal periodV S Blanchette, R A Sacher, P J Ballem, et al.
Schweizerische Medizinische Wochenschrift|August 5, 1978
[Drug induced agranulocytosis. Improved prognosis due to better supportive care]H P Honegger, M Graf, A von Felten, et al.
Pageof 12